InsiderTrades

Form 4 for RVMD Revolution Medicines, Inc.

Accepted 2025-10-20 00:00:00 ET · period of report 2025-10-16 · accession 0001610717-25-000367 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2025-10-20 2025-10-16+ RVMD GOLDSMITH MARK A See Remarks, Dir M - OptEx $1.12 +20.0K 462.3K +5% +$22.4K
DMT 2025-10-20 2025-10-16+ RVMD GOLDSMITH MARK A See Remarks, Dir S - Sale+OE $52.73 -20.0K 452.3K -4% -$1.05M
DMT 2025-10-20 2025-10-16+ RVMD GOLDSMITH MARK A See Remarks, Dir M - OptEx $0.00 -20.0K 26.5K -43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-10-16 M A 10,000 $1.12 462,309 D — — (F2) Includes 193,475 restricted stock units.
2 Common Common Stock 2025-10-17 M A 10,000 $1.12 462,309 D — — (F2) Includes 193,475 restricted stock units.
3 Common Common Stock 2025-10-17 S D 10,000 $55.00 452,309 D — — (F2) Includes 193,475 restricted stock units.
4 Common Common Stock 2025-10-16 S D 10,000 $50.47 452,309 D — — (F3) This transaction was executed in multiple trades at prices ranging from $50.00 to $50.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes 193,475 restricted stock units.
5 Derivative Stock Option (Right to Buy) 2025-10-16 M D 10,000 $0.00 36,479 D $1.12 · 2022-03-29 to 2028-04-19 10,000 Common Stock
6 Derivative Stock Option (Right to Buy) 2025-10-17 M D 10,000 $0.00 26,479 D $1.12 · 2022-03-29 to 2028-04-19 10,000 Common Stock